chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Hypoaesthesia oral, Neck pain
Clinical narrative: Forehead lips numb; Aches in neck; Aches in  shoulders; Forehead lips numb; This is a spontaneous report received from a contactable consumer, the patient. A 61 years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route administration in the left arm on 25Mar2021 at 14:00 (at the age of 61-year-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient was allergic to naproxen. The concomitant medications included unspecified blood pressure medication, zinc (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3) all taken unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 05:30, the patient experienced forehead lips numb, aches in neck and shoulders. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of events forehead lips numb, aches in neck and shoulders were not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site inflammation, Vaccination site pruritus
Clinical narrative: Small itchy inflamed spot at injection site; Small itchy inflamed spot at injection site; Dull manageable headaches; This is a spontaneous report from a contactable consumer, the patient. A 33-years old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the right arm on 18Mar2021 at 14:15 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. It was reported that the patient had known multiple allergies. Concomitant medications included norethindrone acetate (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN) all for an unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 12:00, patient experienced small itchy inflamed spot at injection site, comparable to a medium sized mosquito bite and dull manageable headaches for the last few days, but could be from seasonal allergies. No treatment was received for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events small itchy inflamed spot at injection site, dull manageable headaches was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dry skin, Eczema, Peripheral swelling, Pruritus
Clinical narrative: Itching; Scaliness of the skin, Similar to eczema; Scaliness of the skin, Similar to eczema; swelling of the right leg, Now also swelling in left leg.; dryness of skin; chills; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route, administered in Left Arm on 04Mar2021 at 13:30 (76-year-old at time of vaccination) as a Dose 1, single for Covid-19 immunization. The patient's medical history included diabetes mellitus, blood pressure. The patient received diabetic medication and blood pressure medications within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as Hospital. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 infection. On an unknown date in 2021, the patient had experienced itching, scaliness of the skin, similar to eczema, swelling of the right leg, dryness of skin, chills. Now also swelling in left leg. The adverse event resulted the patient to visit Doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19 infection. The patient received antibiotics, benadryl, lotion for skin as treatment medications for the resulted events. The outcome of the events was not recovered.  Information on the batch/lot number has been requested.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Skin exfoliation
Clinical narrative: Itching; Scaliness of the skin, Similar to eczema; Scaliness of the skin, Similar to eczema; swelling of the right leg, Now also swelling in left leg.; dryness of skin; chills; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route, administered in Left Arm on 04Mar2021 at 13:30 (76-year-old at time of vaccination) as a Dose 1, single for Covid-19 immunization. The patient's medical history included diabetes mellitus, blood pressure. The patient received diabetic medication and blood pressure medications within 2 weeks of vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as Hospital. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 infection. On an unknown date in 2021, the patient had experienced itching, scaliness of the skin, similar to eczema, swelling of the right leg, dryness of skin, chills. Now also swelling in left leg. The adverse event resulted the patient to visit Doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19 infection. The patient received antibiotics, benadryl, lotion for skin as treatment medications for the resulted events. The outcome of the events was not recovered.  Information on the batch/lot number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Hypomenorrhoea, Muscular weakness
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH; Lot number: ER8727) via an unspecified route of administration in the right arm on 23Mar2021 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis, depression and anxiety. The concomitant medication included bupropion hydrochloride (WELLBUTRIN XL) 300 mg daily for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 13:45, patient experienced headache, dizziness, muscle weakness, joint pain throughout entire right side of her body and had very early menstruation. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events headache, dizziness, muscle weakness, joint pain throughout entire right side of body and very early menstruation were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Pyrexia
Clinical narrative: flu like; Fever; Pounding headache; Ache joints; This is a spontaneous report received from a contactable non-health care professional (parent) reporting on behalf of a patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 24Mar2021 at 15:15 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient has not received any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 18:00, the patient experienced fever, pounding headache, ache joints and flu like. It was reported as the patient had called doctor to let them know that had received the first dose and doctor gave her instructions to stay at home to let it pass unless worsening. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, pounding headache, ache joints and flu like were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Feeling cold, Headache
Clinical narrative: Headache; Chills; coldness; achy bones; This is a spontaneous report from a contactable nurse, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 01Mar2021 at 18:00 (at the age of 59-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 60-years-old); as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food, or other products. Concomitant medication included ibuprofen (ADVIL) from unknown date for unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On an unspecified date in Mar2021, after receiving the first dose, the patient experienced chills, coldness, achy bones for 2 days and headache for 14 days. After the second dose, patient had milder symptoms and for shorter duration. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events achy bones, chills, coldness and headache was recovered on an unspecified date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Heart rate, Heart rate increased, Hypersensitivity, Oxygen saturation
Clinical narrative: My throat was really scratchy; Had an increase of mucas production; Allergic reaction; Coughing periodically; Heart rate was elevated to 138; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 37-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration, administered in right arm on 24Mar2021, 19:15 (age at vaccination was 37 years & no pregnant) (Batch/Lot Number: ER2613) as dose 1, single for covid-19 immunization. Medical history included Allergies to medications, food, or other products: Clindamycin, pneumonia vaccination, dust, & seasonal allergies, asthma. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 24Mar2021, at 19:30 after receiving the vaccine the patient experienced to begin coughing periodically. 5-10minutes later the cough intensified because the nurse on hand did not know how to address her reaction the patient used her rescue inhaler, that did not work. The nurse provided her with a hall and some water. The patient's heart rate was elevated to 138. her oxygen levels showed 100. her throat was really scratchy, and she had an increase of mucas production. When she got to the car, she took some of her daughter's children's Benadryl. It did not work all the way. Then she wound up being treated in the ER for an allergic reaction and administered additional Benadryl and Decadron intravenously. The events resulted in Emergency room visit and physician's office. The patient underwent lab tests and procedures which included heart rate: 138, oxygen saturation: 100 on an unspecified date. The patient received treatment for the events. The outcome of the events was recovering.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Secretion discharge, Throat irritation
Clinical narrative: My throat was really scratchy; Had an increase of mucas production; Allergic reaction; Coughing periodically; Heart rate was elevated to 138; This is a spontaneous report from a contactable consumer or other non hcp (patient).   A 37-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration, administered in right arm on 24Mar2021, 19:15 (age at vaccination was 37 years & no pregnant) (Batch/Lot Number: ER2613) as dose 1, single for covid-19 immunization. Medical history included Allergies to medications, food, or other products: Clindamycin, pneumonia vaccination, dust, & seasonal allergies, asthma. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 24Mar2021, at 19:30 after receiving the vaccine the patient experienced to begin coughing periodically. 5-10minutes later the cough intensified because the nurse on hand did not know how to address her reaction the patient used her rescue inhaler, that did not work. The nurse provided her with a hall and some water. The patient's heart rate was elevated to 138. her oxygen levels showed 100. her throat was really scratchy, and she had an increase of mucas production. When she got to the car, she took some of her daughter's children's Benadryl. It did not work all the way. Then she wound up being treated in the ER for an allergic reaction and administered additional Benadryl and Decadron intravenously. The events resulted in Emergency room visit and physician's office. The patient underwent lab tests and procedures which included heart rate: 138, oxygen saturation: 100 on an unspecified date. The patient received treatment for the events. The outcome of the events was recovering.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: blood in urine 10 days after vaccination.; This is a spontaneous report received from a contactable consumer, the patient. A 75-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 12:30 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included left nephrectomy in 2010, irritable bowel syndrome (IBS). Concomitant medications included thyroid (ARMOUR THYROID) and tamsulosin hydrochloride (FLOMAX); both from an unknown date and an unspecified indication. The patient was a known allergic to opiates and lactose. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 17:30, the patient experienced blood in urine ten days after vaccination. The event resulted in doctor or other healthcare professional office or clinic visit. The patient received antibiotics as treatment for the event blood in urine. The clinical outcome of the event blood in urine was recovering.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Chromaturia, Fatigue, Vomiting
Clinical narrative: dark urine; back pain; fatigue; extreme chills; vomited overnight; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via unspecified route of administration in the left arm on 16Mar2021 at 11:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included hiatal hernia, chronic heartburn, hay fever and high blood sugar. The patient had a history of allergy to penicillin and sensitive to aspirin. Concomitant medications included women multi vitamins (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) all for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN9581), via unspecified route of administration in the left arm on 23Feb2021 at 11:30 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 21:30, the patient had experienced extreme chills and vomited once over night and on 17Mar2021, the patient woke up and had 3 or more occasions of dark urine, back pain, more chills and fatigue. Adverse events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if the patient had received any therapeutic measures for the reported events. The clinical outcome of the events extreme chills, vomited overnight, dark urine, back pain and fatigue was resolved on unknown date in Mar2021.  No follow-up attempts are needed. No further information expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site nodule
Clinical narrative: Red spot at injection site; nodule under the skin at injection site; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021, (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disorder (COPD), diabetes and hepatitis C virus genotype 4 (HCV4a). Concomitant medication included acetylsalicylic acid (BABY ASPIRIN) from an unspecified date for an unspecified indication. Prior to vaccination, the patient was diagnosed not with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 23Feb2021, at 16:00, (at the age of 72-years-old) as a single dose for COVID-19 immunisation. On 18Mar2021, at 16:00, the patient experienced red spot at injection site spread to 3 inches by 2 inches (vaccination site erythema) with a 1 inch by 3/4inch nodule under the skin (vaccination site nodule) which developed immediately. It was reported that, the patient still had events under the skin at the time of report (8 days from of event onset). The adverse events were resulted in doctor or other healthcare professional office. The treatment received included heat application to reduce the knot. The clinical outcome of events red spot at injection site and nodule under the skin at injection site not resolved at the time of this report. No follow-up are attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Heart rate, Heart rate increased
Clinical narrative: I see all my heart up in my neck, definitely is speeding; higher blood pressure; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ETV6204), dose 1 via an unspecified route of administration on 16Mar2021 as DOSE 1 SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, probably a day or two days later, the patient experienced higher blood pressure and he took high blood pressure pill (Unspecified medication) and the patient do not necessarily had access to a blood pressure comforted measured, but the patient do reorganize the fact that the patient see all his heart up in neck, definitely was speeding and the patient had tried to, not called or have not seen a doctor yet, it was that want to manage itself. After reading the adverse reaction to the shot decided that should just call and see what was going on because now concerned about taking the second one. The event outcome was Unknown.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Pins and Needles; This is a spontaneous report from a contactable consumer, the patient. A 48-years-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration in the left arm on 25Mar2021 (at the age of 48 years), as a single dose for COVID-19 immunisation. Medical history included Multiple Sclerosis, hypertension, Hypothyroid. The patient was allergic to Macrobid. Medications received within two weeks of vaccination include Synthroid (MANUFACTURER UNKNOWN), Sertraline (MANUFACTURER UNKNOWN), Copaxone (MANUFACTURER UNKNOWN), Simvastatin (MANUFACTURER UNKNOWN) since an unknown date for unknown indications. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, 12 hours after the first dose, the patient experienced pins and needles sensation in random various spots all over the body. The patient had not received any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event pins and needles sensation was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Secretion discharge, Sneezing
Clinical narrative: Severe sneezing; Severe mucus production; severe nasal congestion.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in left arm on 26Mar2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not take any concomitant medication. No known allergies were reported by the patient. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021, the patient experienced severe sneezing, severe mucus production and severe nasal congestion. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events severe sneezing, severe mucus production and severe nasal congestion were not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria, Vaccination site pain
Clinical narrative: Sore arm at injection site for 2-3 days.; Itchy; Hives all over my bodyincluding, arms stomach, breast, back,thighs buttocks.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER- BIONTECH COVID-19 m RNA vaccine, lot no: UNKNOWN) via an unspecified route of administration in left arm on 23Mar2021 at 10:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) and cetirizine (MANUFACTURER UNKNOWN) both taken for an unknown indication since an unspecified date. It was reported that the patient was allergic to codeine. Prior to vaccination, the patient had not tested for COVID-19. The patient had not tested for COVID-19 since having the vaccine. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021 at 08:00, the patient experienced vaccination site pain, itchy and hives. The patient had sore arm at injection site for 2-3 days, Itchy, hives all over my body including, arms stomach, breast, back, thighs and buttocks. The events had not resulted in visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of the adverse events vaccination site pain, itchy and hives. The clinical outcome of the events vaccination site pain, itchy and hives were not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: Intense headache; Chills; low grade fever; Aches; minor soreness in my right arm; This is a spontaneous report received from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EP6955) via unspecified route of administration in the right arm on 25Mar2021 at 09:30 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. The patient did not have a medical history reported. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The concomitant medications included norethisterone acetate; ethinylestradiol; ferrous fumarate (BLISOVI 24 FE ORAL) and cetirizine hydrochloride (ZYRTEC) since unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3247) via an unspecified route of administration in the right arm on 04Mar2021 at 09:30 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. On 25Mar2021 at 21:30, the patient experienced intense headache, chills, low grade fever, aches and minor soreness in her right arm. The patient also reported that it was very difficult to sleep through the night and the chills, feverish feeling and aches lasted for roughly 24 hours. The headache lasted for roughly 30 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the events. The clinical outcome of the events chills, low grade fever, headache, aches and pain in arm was recovered on an unknown date.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: had the worst headache/The pain was awful; vomited; This is a spontaneous report from a contactable nurse. A 47-years-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: En6208) via an unspecified route of administration and administered in right arm on 20Mar2021 11:45 (at age of 47 years) as single dose for COVID-19 immunization. The patient medical history include: About a year ago had low blood platelets. Asthma. HBP and No known allergies. The patients concomitant medication include hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ), curcuma longa (TURMERIC [CURCUMA LONGA]), fluticasone propionate, salmeterol xinafoate (ADVAIR) and MULTIVITAMINS [ASCORBIC ACID; ERGOCALCIFEROL; FOLIC ACID; NICOTINAMIDE; PANTHENOL; RETINOL; RIBOFLAVIN; THIAMINE HYDROCHLORIDE]. No COVID prior vaccination. The patient historical vaccine included first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: En6202) via an unspecified route of administration and administered in left arm on 27Feb2021 10:15 as single dose for COVID-19 immunization. There was no other vaccine in four weeks, prior vaccination patient was not diagnosed with COVID-19 and since vaccination the patient not tested for COVID-19. The patient experienced had the worst headache/the pain was awful, had to go to ER. she do not suffer from migraines and patient experienced vomiting on 25Mar2021 at 09:30 am on Thursday-morning when she woke up. Therapeutic measures were taken as a result of headache with cocktail and Something for the vomiting. IV. The reporter considered the seriousness of events as medically significant. The outcome of events was considered as resolving.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Feeling hot, Headache, Nausea, Neck pain
Clinical narrative: Back pain; Neck pain; Head pain; Nausea; Fever; Feel warm almost 24 hours out; This is a spontaneous report from a non-contactable consumer, the patient. A 23-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via unspecified route of administration in the right arm on 26Mar2021 at 11:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) for treatment of adverse event. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in the right arm on 05Mar2021 at 11:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient had just sore arm after first dose. The patient was known allergic to sulfa medicines, amoxicillin, eggs, milk, cheese, wheat, gluten and ragweed. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 21:00, the patient experienced back pain that made it difficult to stand which spread to head and neck. Within couple of hours, the patient felt nauseous and felt as if she had fever. The patient reported that she never registered a temperature higher than 99.0 F. she experienced this for 12 hours before the pain stopped. The patient still had slight nausea and feel warm almost 24 hours out, but no where near as bad as she did before. Therapeutic measures were taken with ibuprofen for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events, back pain, neck pain, head pain ,nausea, feeling warm and fever was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Back pain; Neck pain; Head pain; Nausea; Fever; Feel warm almost 24 hours out; This is a spontaneous report from a non-contactable consumer, the patient. A 23-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via unspecified route of administration in the right arm on 26Mar2021 at 11:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) for treatment of adverse event. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in the right arm on 05Mar2021 at 11:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient had just sore arm after first dose. The patient was known allergic to sulfa medicines, amoxicillin, eggs, milk, cheese, wheat, gluten and ragweed. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 21:00, the patient experienced back pain that made it difficult to stand which spread to head and neck. Within couple of hours, the patient felt nauseous and felt as if she had fever. The patient reported that she never registered a temperature higher than 99.0 F. she experienced this for 12 hours before the pain stopped. The patient still had slight nausea and feel warm almost 24 hours out, but no where near as bad as she did before. Therapeutic measures were taken with ibuprofen for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events, back pain, neck pain, head pain ,nausea, feeling warm and fever was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Woke up 7 days after receiving the vaccine and am extremely dizzy; Was very dizzy the day of the vaccine but that went away; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the right arm on 19Mar2021 at 12:00 (at the age of 55-years-old), as single dose for COVID-19 immunisation. The patient had no medical history and no known allergies to medications, food, or other products. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), potassium sulfate (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 19Mar2021, on the day of vaccination, the patient was very dizzy but that went away. On 27Mar2021 at 06:00, 7 days after receiving the vaccine, the patient woke up and was extremely dizzy. It had been going on for 3-4 hours and had not subsided at all. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the dizzy with onset of 19Mar2021 was recovered, while clinical outcome dizzy with onset of 27Mar2021 was not recovered at the time of this report.   No follow up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Vaccination site pain
Clinical narrative: Injection site pain; Tiredness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EB8732), via an unspecified route of administration in the left arm on 26Mar2021 at 14:00(at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ZICAM and calcium supplement (MANUFACTURER UNKNOWN)from unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 17:45, the patient experienced injection site pain, tiredness and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the vaccination site pain, tiredness and chills was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Urticaria
Clinical narrative: No sore arm until day 3; Ended up with 5 welts or hive like marks down the arm of the injection site; Being tired first few days; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 15Mar2021 at 09:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included childhood asthma, seasonal allergies, allergic to cats, iodine allergy and fruit allergy (bananas and avocado and peaches). Concomitant medications included escitalopram oxalate (LEXAPRO) from unknown date for unknown indication. The patient also had known allergies to morphine. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 17Mar2021 at 02:00, patient experienced pain in arm, hives and tiredness. The patient reported no sore arm until day 3, ended up with 5 welts or hive like marks down the arm of the injection site. And only one on the other arm. There were no other symptoms except being tired for first few days. The hives were still present. The patient did not receive any treatment for reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the reported events pain in arm, hives and tiredness was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Chronic diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 26Mar2021 at 16:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive other medications with in two weeks of vaccination. The patient had no known allergies. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested for COVID-19 since having the vaccine. On 27Mar2021 at 06:00, patient experienced chronic diarrhea. The patient had not received any treatment for the adverse event. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event chronic diarrhea was resolving.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Nausea, Pain
Clinical narrative: 99.8 fever; Body chills; Bodyaches; Nausea; Shortness of breath; throwing up; This is a spontaneous report from a contactable other healthcare professional, the patient. A 51-year-old female patient received the unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; Er8733) via an unspecified route of administration in left arm on 26Mar2021 at 16:00 (at the age of 51-years-old) as single dose for COVID-19 immunisation. The patient medical history was reported as "I'm in very good health". The patient did not have allergies to medications, food, or other products. Concomitant medication included unspecified HRT (hormone replacement therapy). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Mar2021 at 08:00, the patient experienced 99.8 (units unspecified) fever, body chills, body aches, nausea, throwing up, and shortness of breath. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events 99.8 (units unspecified) fever, body chills, body aches, nausea, throwing up, and shortness of breath were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: 99.8 fever; Body chills; Bodyaches; Nausea; Shortness of breath; throwing up; This is a spontaneous report from a contactable other healthcare professional, the patient. A 51-year-old female patient received the unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; Er8733) via an unspecified route of administration in left arm on 26Mar2021 at 16:00 (at the age of 51-years-old) as single dose for COVID-19 immunisation. The patient medical history was reported as "I'm in very good health". The patient did not have allergies to medications, food, or other products. Concomitant medication included unspecified HRT (hormone replacement therapy). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Mar2021 at 08:00, the patient experienced 99.8 (units unspecified) fever, body chills, body aches, nausea, throwing up, and shortness of breath. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive treatment for the reported events. The clinical outcomes of the events 99.8 (units unspecified) fever, body chills, body aches, nausea, throwing up, and shortness of breath were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Contusion, Epistaxis, Fatigue
Clinical narrative: Migraine with aura; Burning pain along her right side; prolonged nosebleed; bruise developed under right eye; mouth ulcer; Joint pain; Stiffness; Stomach pain; headache; arm soreness; Severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patients medical history included Bechet's disease. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 since having the vaccine. The patient experienced normal headache and arm soreness after 48 hours of vaccination and severe fatigue on 22Mar2021 and prolonged nosebleed, a bruise developed under her right eye, mouth ulcer, joint pain, stiffness, and stomach pain on 23Mar2021 and had another nose bleed on 24Mar2021 and migraine with aura and unusual burning pain along her right side on 25Mar2021. The patient did not receive any treatment for the reported events. The clinical outcome of the events headache, arm soreness, fatigue, nosebleed, bruising, mouth ulcer, joint pain, stiffness, stomach pain, migraine with aura and burning pain was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine with aura, Mouth ulceration, Musculoskeletal stiffness, Pain
Clinical narrative: Migraine with aura; Burning pain along her right side; prolonged nosebleed; bruise developed under right eye; mouth ulcer; Joint pain; Stiffness; Stomach pain; headache; arm soreness; Severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patients medical history included Bechet's disease. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 since having the vaccine. The patient experienced normal headache and arm soreness after 48 hours of vaccination and severe fatigue on 22Mar2021 and prolonged nosebleed, a bruise developed under her right eye, mouth ulcer, joint pain, stiffness, and stomach pain on 23Mar2021 and had another nose bleed on 24Mar2021 and migraine with aura and unusual burning pain along her right side on 25Mar2021. The patient did not receive any treatment for the reported events. The clinical outcome of the events headache, arm soreness, fatigue, nosebleed, bruising, mouth ulcer, joint pain, stiffness, stomach pain, migraine with aura and burning pain was not recovered.   No follow-up attempts are needed. No further information is expected.